Laparoscopic Transversus Abdominis Plane (TAP) Block to Reduce Post-operative Opioids
Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
In this study we aim to investigate the efficacy of laparoscopic-guided TAP block in reducing
post-operative opioid use following minimally invasive foregut and bariatric surgeries. We
will also compare and report the analgesia produced by Bupivacaine HCL vs Exparel ®, a
prolonged slow release Liposomal Bupivacaine formulation. Secondary outcomes assessed will be
VAS pain scores, length of stay, and PONV dosage administered.